Evidence map›Paper›PMID 30410124›Full record

ArticleNature2018

Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer.

Marco Seehawer, Florian Heinzmann, Luana D'Artista, Jule Harbig, Pierre-François Roux, Lisa Hoenicke, Hien Dang, Sabrina Klotz, Lucas Robinson, Grégory Doré and 14 more

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Necroptosis in Down Syndrome.Cell death & disease · 2026
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 13 institutions in 5 countries.

Marco Seehawer *Department of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
Florian Heinzmann *Department of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
Luana D'ArtistaDepartment of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
Jule HarbigDepartment of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
Pierre-François RouxInstitut Pasteur, Nuclear Organization and Oncogenesis Unit, Department of Cell Biology and Infection, Paris, France.
Lisa HoenickeDepartment of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
Hien DangLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Sabrina KlotzDepartment of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
Lucas RobinsonInstitut Pasteur, Nuclear Organization and Oncogenesis Unit, Department of Cell Biology and Infection, Paris, France.
Grégory DoréInstitut Pasteur, Nuclear Organization and Oncogenesis Unit, Department of Cell Biology and Infection, Paris, France.
Nir RozenblumInstitut Pasteur, Nuclear Organization and Oncogenesis Unit, Department of Cell Biology and Infection, Paris, France.
Tae-Won KangDepartment of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
Rishabh ChawlaDepartment of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany.
Thorsten BuchInstitute of Laboratory Animal Science University of Zurich, University of Zurich, Schlieren, Switzerland.
Mihael VucurRWTH University Hospital Aachen, Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), Aachen, Germany.
Mareike RothResearch Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
Johannes ZuberResearch Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
Tom LueddeRWTH University Hospital Aachen, Department of Gastroenterology, Digestive Diseases and Intensive Care Medicine (Department of Medicine III), Aachen, Germany.
Bence SiposInstitute of Pathology, University of Tuebingen, Tuebingen, Germany.
Thomas LongerichInstitute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Mathias HeikenwälderDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Xin Wei WangLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Oliver BischofInstitut Pasteur, Nuclear Organization and Oncogenesis Unit, Department of Cell Biology and Infection, Paris, France.
Lars ZenderDepartment of Internal Medicine VIII, University Hospital Tuebingen, Tuebingen, Germany. lars.zender@med.uni-tuebingen.de.
University of Tübingen · DEFondation ARC pour la Recherche sur le Cancer · FROrganisation Nucléaire et OncogenèseCenter for Cancer Research · USGerman Cancer Research Center · DEInserm · FRNational Cancer Institute · USResearch Institute of Molecular Pathology · ATRWTH Aachen University · DEUniversitätsklinikum Aachen · DEUniversity Hospital Heidelberg · DEUniversity of Zurich · CHVienna Biocenter · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this Article, the pCaMIN construct consisted of 'mouse MYC and mouse Nras

Identifiers

PMID30410124
OpenAlexW2900264060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.